PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 
SMi Group

Press Release


Receive press releases from SMi Group: By Email RSS Feeds:

Superbugs & Superdrugs USA Conference Returns to New Jersey This November


SMi Group reports: agenda released for 3rd annual Superbugs & Superdrugs USA conference.

London, United Kingdom, June 13, 2018 --(PR.com)-- SMi Group is pleased to announce the release of the official agenda for the 3rd annual Superbugs & Superdrugs USA Conference, which is due to take place in Iselin, New Jersey on November 12 - 13, 2018.

Antimicrobial resistance, leading to the development of superbugs, is a major threat to public health and continues to increase as a problem, due to continued misuse of antibiotics. With pharmaceutical companies showing less focus on the development of new antibiotics, several incentive initiatives have been set up - CARBX, BARDA, IMI (EU) - in order to encourage reinvestments. From a governmental point of view, the challenge lies in encouraging companies to develop new antimicrobial drugs and to strengthen and maintain the pipeline of antibiotics and other antimicrobials currently being developed.

Topics for discussion: pathogen focused drug development; methods to overcome bacterial resistance through novel modes of action; developments within the antifungal space; funding opportunities which support antibacterial research and development; case-study examples of rapid diagnostic methods currently being used within the field.

Speakers include:
· Anthony Simon Lynch, Senior Scientific Director, Janssen
· William Weiss, Director, Pre-Clinical Services, UNT Health Science Center
· Tina Guina, Program Officer, Drug Development Section, NIAID/NIH
· Mark Albrecht, Project Officer, HHS/ASPR/BARDA
· Antonio DiGiandomenico, Principal Scientist, MedImmune
· Andrew Tomaras, VP & Director of Microbiology, Bacterioscan
· Dan Pevear, Sr Vice President & Director of Microbiology, VenatoRx
· Ian Friedland, Clinical Consultant, ex-CMO, Achaogen

Topical workshops on November 14:
· Rapid diagnostics for drug resistance: Are we there yet?
· Avoiding the post antibiotic era: the challenges and solutions to successful commercialisation of new antibiotics

Further details at http://www.superbugs-usa.com/prcom

Twitter - @SMIpharm & #smibugs
LinkedIn - SMi Pharma

Contact:
+44 (0)20 7827 6000
ldurneva@smi-online.co.uk
Contact Information
SMi Group
Lyudmyla Durneva
+44 (0) 207 827 6000
Contact
http://www.superbugs-usa.com/prcom

Click here to view the list of recent Press Releases from SMi Group
Promote Your Business